Skip to main content

Table 3 Postoperative adverse events before and after propensity score matching analysis in UICC T3 HCC patients

From: Comparison of hepatic resection and transarterial chemoembolization for UICC stage T3 hepatocellular carcinoma: a propensity score matching study

Variables Before PSM After PSM
TACE (n = 899) HR (n = 280) P value TACE (n = 244) HR (n = 244) P value
Pain (0–2/3–4) 899/1 278/2 0.142* 243/1 243/1 1.0
Edema (0–2/3–4) 899/2 277/3 0.031* 243/1 242/2 1.0*
Fever (0–2/3–4) 883/16 267/13 0.007 241/3 240/4 1.0*
Vomiting (0–2/3–4) 888/11 278/2 0.70# 238/6 242/2 0.285*
Ascites (0–2/3–4) 896/3 275/5 0.03# 242/2 240/4 0.686*
Pleural effusion (0–2/3–4) 897/2 264/16 < 0.01# 243/1 231/13 0.01
UGIH/POH (0–2/3–4) 897/2 278/2 0.241* 243/1 242/2 1.0*
Renal failure (0/1–2) 896/3 279/1 1.0* 243/1 242/2 1.0*
Liver dysfunction (0–2/3–4) 898/1 278/2 0.142* 243/1 243/1 1.0
Bile leakage (n/y) 898/1 279/1 0.422* 244/1 243/1 1.0*
TRD 897/2 277/3 0.090* 243/1 243/1 1.0*
  1. Abbreviations: UICC the Union for International Cancer Control, UGIH upper gastrointestinal hemorrhage, POH postoperative hemorrhage, TRD treatment-related death, PSM propensity score matching
  2. * Fisher’ exact test. # χ2 test with a continuity correction